Oncoinvent ASA - Mandatory notification of trade

Reference is made to the private placement (the "Private Placement") announced by Oncoinvent ASA on 22 September 2026. Please see the attached PDMR-forms for primary insiders and close associates related to allocation of shares in the Private Placement.

PDMR attachement 22.09.2026.pdf (https://mb.cision.com/Public/15728/4399514/956a83e81964cc9f.pdf)

This information is published in accordance with article 19 of the EU Market Abuse Regulation (MAR).

For further information, please contact:

Oystein Soug, Chief Executive Officer Email: IR@oncoinvent.com